A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis
NCT01140503
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class
Stopped
Slow recruitment of participants
Conditions
Dermatomyositis
Interventions
DRUG:
Apremilast
Sponsor
Stanford University